Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.2.0 to v3.3.2, a change to metadata rather than study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the site-wide banner about funding lapses and NIH operating status, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor non-substantive updates were detected, such as a revised last-updated timestamp and small formatting changes; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:05:15.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update to version 3.2.0 and removal of a specific disease resource; plus a government-operating status notice added.
    Difference
    3%
    Check dated 2025-10-06T05:35:21.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:46.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a minor update. The 'Back to Top' element was removed, with no substantive changes to core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-14T19:12:43.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.